Cervical screening uptake could increase with better patient advice

HPV education programmes could increase the uptake of cervical screening, a survey of British women suggests.

Credit: Haymarket Medical/J H Lancy
Credit: Haymarket Medical/J H Lancy

Researchers asked 195 women aged 26-27 whether they would still go for cervical screening after being vaccinated for HPV.

The women were asked before and after they were given information about cervical cancer, HPV and vaccination.

The proportion of women who said they would continue to go for cervical screening after being vaccinated increased from 22% to 60% after being given the information.

The women questioned had previously missed a cervical screening appointment.

The survey was funded by GlaxoSmithKline, manufacturer of the HPV vaccine Cervarix.

tom.moberly@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GP consulting room

Nine in ten GPs fear their practice will struggle to cope this winter

Nearly nine in ten GPs fear that their practice will struggle to cope this winter,...

UK money

Almost half of practices say income from private fees has fallen in past year

Almost half of GP practices have seen their income from private and professional...

COVID-19 vaccination centre

BMA raises 'serious concerns' about GP workload and funding for autumn COVID boosters

The BMA has raised 'serious concerns' about the workload implications of this autumn's...

Vaccines

Monkeypox jabs will run out by next week, UKHSA says

The UK is likely to run out of smallpox vaccine stocks which it is using to protect...

NHS sign outside a building

Two Midlands hospitals end partnerships with Babylon

Two NHS trusts have prematurely severed their relationships with digital health provider,...

Person receiving a COVID-19 booster

JCVI sets out which vaccines to use for autumn COVID-19 boosters

The Joint Committee on Vaccinations and Immunisations (JCVI) has said that Moderna's...